These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27983837)

  • 21. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting inactive conformations of protein kinases using active structures: conformational selection of type-II inhibitors.
    Xu M; Yu L; Wan B; Yu L; Huang Q
    PLoS One; 2011; 6(7):e22644. PubMed ID: 21818358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures.
    Herrington NB; Li YC; Stein D; Pandey G; Schlessinger A
    PLoS Comput Biol; 2024 Jul; 20(7):e1012302. PubMed ID: 39046952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Free-Wilson selectivity analysis for combinatorial library design.
    Sciabola S; Stanton RV; Johnson TL; Xi H
    Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting conformational plasticity of protein kinases.
    Tong M; Seeliger MA
    ACS Chem Biol; 2015 Jan; 10(1):190-200. PubMed ID: 25486330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free-energy force-field three-dimensional quantitative structure-activity relationship analysis of a set of p38-mitogen activated protein kinase inhibitors.
    Romeiro NC; Albuquerque MG; de Alencastro RB; Ravi M; Hopfinger AJ
    J Mol Model; 2006 Sep; 12(6):855-68. PubMed ID: 16541250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of type-II inhibitors using kinase structures.
    Lovering F; McDonald J; Whitlock GA; Glossop PA; Phillips C; Bent A; Sabnis Y; Ryan M; Fitz L; Lee J; Chang JS; Han S; Kurumbail R; Thorarensen A
    Chem Biol Drug Des; 2012 Nov; 80(5):657-64. PubMed ID: 22759374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pharmacophore map of small molecule protein kinase inhibitors.
    McGregor MJ
    J Chem Inf Model; 2007; 47(6):2374-82. PubMed ID: 17941626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space.
    van Linden OP; Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Med Chem; 2014 Jan; 57(2):249-77. PubMed ID: 23941661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome.
    Vidović D; Muskal SM; Schürer SC
    J Chem Inf Model; 2012 Dec; 52(12):3107-15. PubMed ID: 23121521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinase Crystal Miner: A Powerful Approach to Repurposing 3D Hinge Binding Fragments and Its Application to Finding Novel Bruton Tyrosine Kinase Inhibitors.
    Mukherjee P; Bentzien J; Bosanac T; Mao W; Burke M; Muegge I
    J Chem Inf Model; 2017 Sep; 57(9):2152-2160. PubMed ID: 28792217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor using 2D and 3D techniques.
    Araujo SC; Maltarollo VG; Honorio KM
    Eur J Pharm Sci; 2013 Jul; 49(4):542-9. PubMed ID: 23727056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining the Protein Kinase Conformational Space with Machine Learning.
    Ung PM; Rahman R; Schlessinger A
    Cell Chem Biol; 2018 Jul; 25(7):916-924.e2. PubMed ID: 29861272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening.
    Foloppe N; Fisher LM; Howes R; Potter A; Robertson AG; Surgenor AE
    Bioorg Med Chem; 2006 Jul; 14(14):4792-802. PubMed ID: 16574416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural elucidation of the DFG-Asp in and DFG-Asp out states of TAM kinases and insight into the selectivity of their inhibitors.
    Messoussi A; Peyronnet L; Feneyrolles C; Chevé G; Bougrin K; Yasri A
    Molecules; 2014 Oct; 19(10):16223-39. PubMed ID: 25310149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspective on computational and structural aspects of kinase discovery from IPK2014.
    Martin E; Knapp S; Engh RA; Moebitz H; Varin T; Roux B; Meiler J; Berdini V; Baumann A; Vieth M
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1595-604. PubMed ID: 25861861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolutionary variation and adaptation in a conserved protein kinase allosteric network: implications for inhibitor design.
    Oruganty K; Kannan N
    Biochim Biophys Acta; 2013 Jul; 1834(7):1322-9. PubMed ID: 23499783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase structure and function analysis with chemical tools.
    Shen K; Hines AC; Schwarzer D; Pickin KA; Cole PA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):65-78. PubMed ID: 16213197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplant-insert-constrain-relax-assemble (TICRA): protein-ligand complex structure modeling and application to kinases.
    Meshkat S; Klon AE; Zou J; Wiseman JS; Konteatis Z
    J Chem Inf Model; 2011 Jan; 51(1):52-60. PubMed ID: 21117680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.